We continued checking PD-L1 expression in the TCGA RCC data and other TCGA data sets by TIMER2.0, which revealed that TDO2 not only correlated with PD-L1 expression in RCC but also with other cancers (Fig. 2c, Fig. S2a). This evidence concerns the gene TDO2 and cancer.